ENTRY       D04257                      Drug
NAME        Fospropofol disodium (USAN);
            Aquavan (TN);
            Lusedra (TN)
FORMULA     C13H19O5P. 2Na
EXACT_MASS  332.0766
MOL_WEIGHT  332.2403
CLASS       Neuropsychiatric agent
             DG01567  GABA-A receptor agonist
             DG02030  Anesthetics
              DG02027  General anesthetics
REMARK      ATC code: N01AX10
            Chemical structure group: DG00797
            Product (DG00797): D00549<JP/US>
EFFICACY    Sedative
COMMENT     Active form of prodrug: Propofol [DR:D00549]
TARGET      GABR [HSA:2554 2555 2556 2557 2558 2559 2560 2561 2562 2563 2564 2565 2566 2567 2568 55879] [KO:K05175 K05181 K05184 K05185 K05186 K05189 K05192]
  PATHWAY   hsa04080(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  Neuroactive ligand-receptor interaction
            hsa04727(2554+2555+2556+2557+2558+2559+2560+2561+2562+2563+2564+2565+2566+2567+2568+55879)  GABAergic synapse
INTERACTION  
STR_MAP     map07230  GABA-A receptor agonists/antagonists
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             N NERVOUS SYSTEM
              N01 ANESTHETICS
               N01A ANESTHETICS, GENERAL
                N01AX Other general anesthetics
                 N01AX10 Propofol
                  D04257  Fospropofol disodium (USAN)
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01567  GABA-A receptor agonist
               DG00797  Propofol
                D04257  Fospropofol disodium
              DG02030  Anesthetics
               DG02027  General anesthetics
                DG00797  Propofol
                 D04257  Fospropofol disodium
            Target-based classification of drugs [BR:br08310]
             Ion channels
              Ligand-gated ion channels
               GABA (ionotropic)
                GABR
                 D04257  Fospropofol disodium (USAN)
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D04257
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D04257
            Prodrugs [br08324.html]
             D04257
            Drug groups [BR:br08330]
             Neuropsychiatric agent
              DG01567  GABA-A receptor agonist
               DG00797  Propofol
              DG02030  Anesthetics
               DG02027  General anesthetics
                DG00797  Propofol
DBLINKS     CAS: 258516-87-9
            PubChem: 47206198
            LigandBox: D04257
ATOM        21
            1   C8y C    21.0426  -15.5979
            2   C8y C    22.2600  -14.8989
            3   C1c C    19.8312  -14.8989
            4   C8x C    21.0426  -16.9958
            5   C8y C    23.4714  -15.5979
            6   O2a O    22.2657  -13.5010
            7   C1a C    19.8312  -13.5010
            8   C1a C    18.6196  -15.5979
            9   C8x C    22.2600  -17.7005
            10  C1c C    24.6888  -14.8989
            11  C8x C    23.4714  -16.9958
            12  C1a C    25.9004  -15.5979
            13  C1a C    24.6888  -13.5010
            14  C1b C    23.4729  -12.8107
            15  O2b O    23.4707  -11.4102
            16  P1b P    24.6665  -10.7171
            17  O1c O    25.8790  -10.0171 #-
            18  O1c O    23.9561   -9.4884
            19  O1c O    25.3575  -11.9122 #-
            20  Z   Na   28.5600   -9.9400 #+
            21  Z   Na   28.7000  -12.0400 #+
BOND        19
            1     1   2 1
            2     1   3 1
            3     1   4 2
            4     2   5 2
            5     2   6 1
            6     3   7 1
            7     3   8 1
            8     4   9 1
            9     5  10 1
            10    5  11 1
            11   10  12 1
            12   10  13 1
            13    9  11 2
            14    6  14 1
            15   14  15 1
            16   15  16 1
            17   16  17 1
            18   16  18 2
            19   16  19 1
///
